XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 31 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $4,745,000 | – | 250,000 | – | 0.75% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|